Using oxytocin to enhance couples therapy for veterans with PTSD
Official title: A Randomized Clinical Trial Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
Run by VA Office of Research and Development · NCT06194851 · Data updated 2026-11-12
This study is testing if adding a nasal spray of oxytocin to couples therapy can help veterans with PTSD and their partners feel better and improve their relationship.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (San Diego, California) |
| Status | Recruiting |
| Started | October 28, 2024 |
| Main results expected | September 30, 2028 |
| Study ends | September 30, 2028 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT06194851 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include veterans aged 18 or older with a current diagnosis of PTSD and their intimate partners who are willing to participate.
✕Probably not a fit
Patients who do not have PTSD or those who are not in a stable intimate relationship may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of Brief Cognitive Behavioral Conjoint Therapy (bCBCT) combined with intranasal oxytocin on veterans suffering from PTSD and their intimate partners. The study aims to compare the outcomes of bCBCT augmented with oxytocin against a placebo, focusing on PTSD symptoms, relationship satisfaction, and psychosocial functioning. Participants will undergo eight sessions of therapy while receiving either the oxytocin nasal spray or a saline placebo. The trial also seeks to explore how oxytocin may influence communication, empathy, and trust within the couple's relationship.
Why it matters
Potential benefit: If successful, this approach could significantly improve PTSD symptoms and relationship quality for veterans and their partners.
How similar studies have gone: Previous studies have shown promise in using oxytocin for enhancing therapeutic outcomes, but this specific combination of bCBCT and oxytocin is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
Inclusion criteria for Veteran:
1. Be a Veteran (age 18 or older) with a current DSM-5 diagnosis of PTSD (as assessed by the CAPS-5 with a minimum severity score of 25) no less than 3 months after the index trauma occurred (to allow for potential natural recovery)
2. Be on a stable psychoactive medication regimen for at least 4 weeks (if applicable)
3. Be enrolled and eligible to receive care at the VASDHS
Inclusion criteria for Partner:
4. Be an intimate partner (age 18 or older) who is willing to participate in the intervention (partners can also be Veterans but cannot meet criteria for possible PTSD per the PCL-5)
Inclusion criteria for Veteran and Partner:
5. Be married, or cohabitating for at least 6 months
6. Willing to be randomized into either treatment condition (bCBCT + OT or bCBCT + PL)
7. Agree to have assessment and treatment sessions audio/video recorded
8. Agree not to receive other individual trauma-focused psychotherapy for PTSD or any form of conjoint therapy during the treatment portion of the study
9. Have the capacity to participate in virtual care (access to internet via DSL or a cable provider, private space)
Exclusion Criteria:
Exclusion criteria for Veteran and Partner:
10. Current substance dependence in either member of the couple not in remission for at least 3 months, as assessed by the Alcohol Use Disorders Identification Test (AUDIT)74 and Drug Abuse Screening Test (DAST)75
11. Any current uncontrolled psychotic disorder in either member of the couple as assessed by positive screen on the Prime Screen-Revised (PS-R). Exclusion to be determined following case consult by PI or other clinician.
12. Imminent suicidality or homicidality in either member of the couple (e.g., C-SSRS)
13. Any severe cognitive or medical impairment in either member of the couple making it difficult to regularly attend weekly couples psychotherapy
14. Any perpetration of severe physical or sexual relationship aggression (as assessed by the CTS-2) or fear/intimidation (3-item IPV screen, Couples Questionnaire) in the past year
Exclusion criteria for Veteran:
15. Severe ongoing medical problems, including heart disease, uncontrolled hypotension (systolic blood pressure \<100 mm Hg) or hypertension (systolic BP \>130 or diastolic BP \> 80 mm Hg), and neuroendocrinological disorders (e.g., diabetes). Exclusion to be determined in collaboration with study physician following completion of physician's one-on-one appointment with Veteran and review of all relevant information (e.g., risk factors, health history, concomitant medications, etc.) from Veteran's VA medical record and study screening/assessment processes including selfreport measures and blood pressure measurement. Additionally, Veterans for whom the study physician has elevated concern, will be asked to attend an in-person visit at a VA medical center, clinic, or the Veterans Medical Research Foundation before enrollment.
16. Positive screen (7+) for borderline personality disorder (BPD) as assessed by the MacLean Screening Instrument for BPD76. Exclusion to be determined following case consult by PI or other clinician.
17. Pregnancy, delivery in the past 6 months, current breastfeeding, or the ability to become pregnant while not practicing an effective method of contraception. If able to become pregnant, Veteran must have a highly sensitive negative urine pregnancy test verified visually via telehealth or in-person at the Veterans Medical Research Foundation by research staff at study entry and prior to each medication administration during treatment. Veteran must verbally confirm that they completed the test themselves that day. Veteran must also agree to use an effective birth control method from study entry until conclusion of treatment to prevent pregnancy. The ability to become pregnant is defined as: assigned female at birth, fertile, following menarche and until becoming post-menopausal unless permanently sterile. Permanent sterilization methods include hysterectomy, bilateral salpingectomy, and bilateral oophorectomy.
Effective birth control methods include intrauterine device (IUD), injected, implanted, intravaginal, or transdermal hormonal methods, oral hormones, a barrier contraception method (e.g., male or female condoms, diaphragm, cap), or vasectomized sole sexual partner.
Pregnancy tests will be purchased by the study and mailed to Veteran unless PI has approved waiver of testing requirement.
18. Known allergy to preservatives (i.e., Methylparaben, Propylparaben, Glycerin, Sodium Benzoate, Potassium Sorbate, and Disodium EDTA) utilized in oxytocin nasal spray.
Where it's running
-
VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States Recruiting
Study contacts
- Principal investigator: Leslie A. Morland, PsyD — VA San Diego Healthcare System, San Diego, CA
- Study coordinator: Leslie A Morland, PsyD
- Email: Leslie.Morland@va.gov
- Phone: (619) 497-8406
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive vagus nerve stimulation (gammaCore) for PTSD
This study will test whether the handheld gammaCore device, which delivers mild electrical stimulation to the vagus nerve through the neck, can help adults with PTSD reduce their symptoms.
-
Building Ukraine's strength in PTSD treatment
This project will try the Reconsolidation of Traumatic Memories (RTM) protocol alongside standard PTSD treatments to see if it reduces symptoms in adults with PTSD living in Ukraine.
-
Emotional dysregulation in adolescents with complex trauma traits
Researchers will observe teens to see how emotional dysregulation shows up in CPTSD and how it differs from BPD and PTSD.
-
Grappling with Trauma: BJJ for First Responders
This program tests whether eight weeks of Brazilian Jiu-Jitsu can be tied to changes in trauma-related symptoms for first responders who prefer movement-based activities over traditional mental health services.
-
Eye Movement Intervention with Different Memory Reactivation Procedures for Intrusive Traumatic Memories
This online trial tests whether combining eye movements with different memory reactivation tasks can reduce intrusive trauma memories in people with PTSD.
-
Trauma-informed Psilocybin-assisted psychotherapy for PTSD
This study tests whether adding psilocybin to trauma-focused psychotherapy helps people with PTSD see if the approach is safe and tolerable and whether symptoms improve.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.